Versigent director acquires 14.65 dividend rights

Versigent PLC director received dividend-equivalent rights tied to prior RSU grants, reflecting a non-cash, derivative-based compensation accrual.

Rhea-AI Filing Summary

Versigent PLC (VGNT) director Brad M. Cerepak reported an acquisition of 14.65 Dividend Equivalent Rights on September 18, 2026. These rights accrued on previously granted restricted stock units due to a dividend declared and paid by Versigent and are the economic equivalent of 14.65 ordinary shares, vesting on the same schedule as the related restricted stock units.

Insider Trade Summary

Grant/Award: 14.65 shares

Grant/Award 1 txn

Insider Cerepak Brad M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	14.65	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 14.65 contracts (Direct)

Footnotes (1)

1. F1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.

Key Figures

Dividend Equivalent Rights acquired: 14.65 rights Transaction price per right: $0.00 per right Dividend Equivalent Rights held after transaction: 14.65 rights +1 more

4 metrics

Dividend Equivalent Rights acquired 14.65 rights Grant/award acquisition on September 18, 2026

Transaction price per right $0.00 per right Non-cash accrual of rights from dividend on RSUs

Dividend Equivalent Rights held after transaction 14.65 rights Direct ownership position following the reported acquisition

Underlying ordinary shares equivalent 14.65 shares Each Dividend Equivalent Right equals one ordinary share

Key Terms

Dividend Equivalent Rights, restricted stock units, ordinary shares

3 terms

Dividend Equivalent Rights financial

"The dividend equivalent rights accrued on grants of restricted stock units"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock units financial

"accrued on grants of restricted stock units as a result of a dividend"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

ordinary shares financial

"Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Versigent PLC (VGNT) report on this Form 4?

The filing reports that director Brad M. Cerepak acquired 14.65 Dividend Equivalent Rights on September 18, 2026. These derivative rights arose from a dividend declared and paid by Versigent on previously granted restricted stock units.

How many Versigent (VGNT) Dividend Equivalent Rights did the director hold after the transaction?

After the reported transaction, the director held a total of 14.65 Dividend Equivalent Rights directly. Each right is tied to an underlying ordinary share and reflects dividend accruals on restricted stock units.

What do the Dividend Equivalent Rights represent for Versigent (VGNT)?

Each Dividend Equivalent Right is the economic equivalent of one ordinary share of Versigent PLC. They accrue on restricted stock units when a dividend is declared and are designed to mirror the value of dividends on the underlying shares.

Do the Versigent (VGNT) Dividend Equivalent Rights vest immediately?

No. The filing states these Dividend Equivalent Rights vest on the same schedule as the restricted stock units to which they relate, aligning their vesting with the original RSU awards rather than providing immediate vesting.

Was there any cash price paid for the Versigent (VGNT) Dividend Equivalent Rights?

No cash price was paid. The transaction price per right is reported as $0.00, reflecting that the rights accrued automatically as a result of a dividend declared and paid on existing restricted stock units.

Are the Versigent (VGNT) Dividend Equivalent Rights related to ordinary shares?

Yes. The filing specifies that each Dividend Equivalent Right is the economic equivalent of one ordinary share of Versigent PLC, and the reported 14.65 rights correspond to 14.65 underlying ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 04:06 PM Accepted by SEC EDGAR 09/22/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cerepak Brad M

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

SCHAFFHAUSEN 8200

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/18/2026		A		14.65		(1)	(1)	Ordinary Shares	14.65	$0.00	14.65	D

Explanation of Responses:

1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.

	/s/ Janis N. Acosta, Attorney-in-fact for Brad M. Cerepak	09/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)